Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. The reaction step limiting heparin turnover in thrombin neutralization
- PMID: 3759953
Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. The reaction step limiting heparin turnover in thrombin neutralization
Abstract
The intrinsic protein fluorescence quenching which accompanies the heparin-accelerated inhibition of thrombin (T) by antithrombin III (AT) was resolved into a heparin-independent component associated with formation of the product T-AT complex and a component associated with an AT conformational change linked to heparin dissociation. To determine whether dissociation of heparin from the product T-AT complex limits the rate at which heparin can turn over catalytically, the kinetics of protein fluorescence quenching during the reaction of thrombin with AT X heparin complex (AT X H) were investigated by stopped-flow fluorimetry under pseudo-first order conditions ([AT X H]o much greater than [T]o). Both fluorescence components were quenched in a single exponential reaction with a hyperbolic dependence of the first order rate constant (kobs) on [AT X H]o. An indistinguishable hyperbolic dependence of kobs on [AT X H]o was measured by displacement of p-aminobenzamidine from the T active site, with both signals extrapolating to a limiting rate constant of 5 s-1. These results indicate that heparin dissociation occurs concomitant with T-AT complex formation at the limiting 5 s-1 rate constant. In reasonable agreement with this value, a kcat of 2.3 s-1 was determined for heparin turnover at catalytic concentrations. We conclude that formation of the T-AT complex is the primary rate-limiting step in heparin catalytic turnover and that this reaction is accompanied by a change in conformation of the AT component resulting in facile heparin dissociation.
Similar articles
-
Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction.J Biol Chem. 1989 Apr 5;264(10):5452-61. J Biol Chem. 1989. PMID: 2925612
-
Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Linkage of protease-inhibitor-heparin interactions in the reaction with thrombin.J Biol Chem. 1988 Feb 5;263(4):1698-708. J Biol Chem. 1988. PMID: 3338989
-
The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.J Biol Chem. 1982 Dec 10;257(23):13899-302. J Biol Chem. 1982. PMID: 7142182
-
Antithrombin III: a backward glance o'er travel'd roads.Adv Exp Med Biol. 1975;52:195-215. Adv Exp Med Biol. 1975. PMID: 47704 Review.
-
Mechanism of heparin action.Baillieres Clin Haematol. 1990 Jul;3(3):483-504. doi: 10.1016/s0950-3536(05)80015-0. Baillieres Clin Haematol. 1990. PMID: 2176902 Review.
Cited by
-
Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.Biochem J. 1992 Sep 15;286 ( Pt 3)(Pt 3):793-800. doi: 10.1042/bj2860793. Biochem J. 1992. PMID: 1417738 Free PMC article.
-
Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.Biochem J. 1995 Aug 15;310 ( Pt 1)(Pt 1):323-30. doi: 10.1042/bj3100323. Biochem J. 1995. PMID: 7646463 Free PMC article.
-
A mathematical model of thrombin production in blood coagulation, Part I: The sparsely covered membrane case.Ann Biomed Eng. 1994 Jul-Aug;22(4):357-70. doi: 10.1007/BF02368242. Ann Biomed Eng. 1994. PMID: 7998681
-
Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor II.J Biol Chem. 2010 Mar 12;285(11):8278-89. doi: 10.1074/jbc.M109.005967. Epub 2010 Jan 6. J Biol Chem. 2010. PMID: 20053992 Free PMC article.
-
A rapid pro-hemostatic approach to overcome direct oral anticoagulants.Nat Med. 2016 Aug;22(8):924-32. doi: 10.1038/nm.4149. Epub 2016 Jul 25. Nat Med. 2016. PMID: 27455511
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical